OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibitors and Activators of the p38 Mitogen-Activated MAP Kinase (MAPK) Family as Drugs to Treat Cancer and Inflammation
William A. Denny
Current Cancer Drug Targets (2022) Vol. 22, Iss. 3, pp. 209-220
Closed Access | Times Cited: 7

Showing 7 citing articles:

Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis
Yu Shan, Jianan Zhao, Yixin Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16

Polyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease
Wesley Harrell Brooks
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 3, pp. 837-857
Open Access | Times Cited: 5

P38 MAPK and Radiotherapy: Foes or Friends?
Natalia Flores, Jaime Jiménez‐Suárez, Cristina Garnés‐García, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 861-861
Open Access | Times Cited: 7

Mitogen activated protein kinase phosphatase 5 alleviates liver ischemia–reperfusion injury by inhibiting TAK1/JNK/p38 pathway
Qiwen Yu, Sanyang Chen, Jiye Li, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5

Therapeutic agents for Alzheimer’s disease: a critical appraisal
Marta Weinstock
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access

Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases
Surya K. De
Recent Patents on Anti-Cancer Drug Discovery (2022) Vol. 18, Iss. 4, pp. 549-551
Closed Access | Times Cited: 1

Page 1

Scroll to top